Journal Report

ANTI-CANCER DRUGS

Download PDF
Journal Information
Journal Title
ANTI-CANCER DRUGS
Publisher
LIPPINCOTT WILLIAMS & WILKINS
ISSN
0959-4973
E-ISSN
1473-5741
Database
Clarivate
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Prochlorperazine inhibits the proliferation of hepatocellular carcinoma cells by promoting phosphorylation of β-catenin
Yongjie Liang, Xiao Wang, Ruifeng Tian et al.
2026-10-7 Vol. 37 Issue 10 Pages 586-596
DOI: 10.1097/cad.0000000000001822
Case report: successful use of repotrectinib in a ROS1 fusion-positive lung adenocarcinoma patient with severe renal insufficiency and prior tyrosine kinase inhibitor treatment failure
Zhengjie Liang, Hao Li
2026-10-7 Vol. 37 Issue 10 Pages 629-633
DOI: 10.1097/cad.0000000000001818
Akt inhibitor-IV in estrogen receptor-positive breast cancer cells: cytotoxic, apoptotic, transcriptional, and in-silico comparison with tamoxifen
Ahmet Karakuş, Orhan Erdoğan
2026-10-7 Vol. 37 Issue 10 Pages 620-628
DOI: 10.1097/cad.0000000000001834
Successful treatment of hairy cell leukemia with TP53 abnormality using cladribine combined with low-dose rituximab: a case report and literature review
Zixin Chen, Lin Chen
2026-10-7 Vol. 37 Issue 10 Pages 638-642
DOI: 10.1097/cad.0000000000001823
Publishing with Anti-Cancer Drugs: what authors should know
Sergio Huerta
2026-10-7 Vol. 37 Issue 10 Pages 583-585
DOI: 10.1097/cad.0000000000001849
Hyperthermia combined with intraperitoneal perfusion of drugs improves malignant ascites caused by gastrointestinal tumors by reshaping the tumor immune microenvironment
Yongjian Zhang, Baomei Wang, Junhua Zhang et al.
2026-10-7 Vol. 37 Issue 10 Pages 597-607
DOI: 10.1097/cad.0000000000001820
Primary resistant disease is clinically heterogeneous in metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
Noriyuki Abe, Ryuma Tanaka, Yuya Sekine et al.
2026-10-6
DOI: 10.1097/cad.0000000000001847
Macrophage-associated epithelial–mesenchymal transition in human breast cancer: contextualizing innate immune sensing programs
Steven Lehrer, Peter Rheinstein
2026-10-5
DOI: 10.1097/cad.0000000000001848
Pathologic complete response after first-line tislelizumab, cetuximab, and dabrafenib in microsatellite-stable BRAF V600E-mutant metastatic colorectal cancer: a case report
Rong Li, Yanping Lin, Jiangyan Guo et al.
2026-9-30
DOI: 10.1097/cad.0000000000001846
3-Aminoisoquinolines inhibit selectively phosphodiesterase 4B in KRAS-mutated colorectal cancer cell lines in-vitro and in-vivo
Gennady B. Lapa, Toshiyuki Tsunoda, Natalia I. Moiseeva
2026-9-9 Vol. 37 Issue 9 Pages 528-535
DOI: 10.1097/cad.0000000000001819
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 8, 2026 04:34